Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2002
12/12/2002WO2002008292A3 Human monoclonal antibody against hepatitis c virus e2 glycoprotein
12/12/2002WO2002004424A9 Pyrazole derivatives
12/12/2002WO2002002098A3 Antibacterial method and composition with phenolic compounds
12/12/2002WO2002002077A3 Liposomal antineoplastic drugs and uses thereof
12/12/2002WO2001097850A3 Combinations and compositions which interfere with vegf/vegf and angiopoietin/tie receptor function and their use (ii)
12/12/2002WO2001097786A3 Benzothiazole derivatives
12/12/2002WO2001095922A1 Remedies for allergic diseases and process for producing the same
12/12/2002WO2001078720A8 Decreasing the intracellular level of beta-catenin by administering hydroxymatairesinol
12/12/2002WO2001054731A3 Ligand conjugates and methods for preparing same
12/12/2002WO2001042272A9 Eplerenone crystalline form exhibiting enhanced dissolution rate
12/12/2002WO2000032152A3 Compositions and methods for regulating bacterial pathogenesis
12/12/2002US20020188202 Method of diagnosis and treatment and related compositions and apparatus
12/12/2002US20020188143 Steroid compounds, use of these compounds for the preparation of meiosis-regulating medicaments and method for the preparation of these compounds
12/12/2002US20020188142 17-Side chain alkynyl-and 20-oxopregna-derivatives of vitamin D, methods for their production and pharmaceutical compositions thereof
12/12/2002US20020188139 P-thienylbenzylamides as agonists of angiotensin-(1-7) receptors, and methods of their preparartion and use
12/12/2002US20020188133 Producing an isoxazolidinedione compound from beta - methyl L-aspartate via an important intermediate oxazolylethanol derivative
12/12/2002US20020188132 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
12/12/2002US20020188128 Substituted imidazo[1,2-A] pyridine derivatives
12/12/2002US20020188124 Novel spiro compounds
12/12/2002US20020188122 Such as pyridine-4-carboxaldehyde-(4-Morpholinylprop-3-yl) imine for use in therapy as cytokine inhibitors
12/12/2002US20020188120 Such as 4-(4-methyoxy-benzenesulfonyl)-1-(3-phenyl-propyl)-piperidine-4-carboxylic acid hydroxyamide for treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone diseases, diabetes, and HIV
12/12/2002US20020188119 Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides
12/12/2002US20020188118 Compounds and methods for the inhibition of the expression of VCAM-1
12/12/2002US20020188100 Boron compound for use in the treatment of stroke, heart defects, inflammation, autoimmune and cancer disease
12/12/2002US20020188029 Methods of treating or preventing weight gain, obesity, and related disorders
12/12/2002US20020188028 Anti-infective compositions, methods and systems for treating disordered tissue
12/12/2002US20020188025 Compositions for promoting sleep
12/12/2002US20020188024 Fatty acid-containing emulsion with increased bioavailability
12/12/2002US20020188023 Compound
12/12/2002US20020188022 Methods for modulation, stimulation, and inhibition of glutamate reuptake
12/12/2002US20020188021 Method of using caffeic acid phenethyl ester and analogs thereof as radiation sensitizers
12/12/2002US20020188020 Aminoindan derivatives
12/12/2002US20020188019 Use of hydroxyflavanones for masking bitter taste
12/12/2002US20020188018 3-indolyl-4-phenyl-1H-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
12/12/2002US20020188017 Thienylazolylalkoxyethanamines, their preparation and their application as medicaments
12/12/2002US20020188016 Heterocycle derivatives and methods of use
12/12/2002US20020188015 Method and composition for rejuvinating cells, tissues organs, hair and nails
12/12/2002US20020188014 Polymorphs of an epothilone analog
12/12/2002US20020188013 Composition for treatment of malignant tumors
12/12/2002US20020188012 Method for treating Alzheimer's disease
12/12/2002US20020188011 Antiviral agents and methods of treating viral infections
12/12/2002US20020188010 Compositions of matter containing L-glutamine and pyridoxal-alpha-ketoglutarate
12/12/2002US20020188009 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
12/12/2002US20020188008 Novel salt form of pantoprazole
12/12/2002US20020188007 Pyrazolecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
12/12/2002US20020188005 Novel methods for the treatment and prevention of ileus
12/12/2002US20020188002 Pharmaceutical composition based on cocaethylene and use thereof for treating psychoactive substance dependence
12/12/2002US20020188000 Imidazo-pyridine derivatives as ligands for gaba receptors
12/12/2002US20020187999 Anti-inflammatory uses of manzamines
12/12/2002US20020187998 Local ophthalmic agent for treatment of ocular inflammation
12/12/2002US20020187997 Phospholipid transfer protein (PLTP) and cholesterol metabolism
12/12/2002US20020187996 Prevention of addiction in pain management
12/12/2002US20020187995 Methods for use in modifying the perception of pain
12/12/2002US20020187994 New compounds
12/12/2002US20020187992 Prodrugs via acylation with cinnamate
12/12/2002US20020187991 Barbituric acid derivatives
12/12/2002US20020187990 Compositions and methods for the treatment of anorectal disorders
12/12/2002US20020187989 Preventive or therapeutic drugs for various eosinophilia-related diseases containg chymase inhibitors as the active ingredient
12/12/2002US20020187987 Use of 2-aminothiazoline derivatives as inhibitors of inducible NO-synthase
12/12/2002US20020187986 Ophthalmic formulation which modulates dilation
12/12/2002US20020187985 Method and composition for the treatment of lipid and glucose metabolism disorders
12/12/2002US20020187982 Glucagon antagonists/inverse agonists
12/12/2002US20020187980 Methods using PTPase inhibitors and insulin
12/12/2002US20020187978 4-Heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
12/12/2002US20020187977 Methods for restoring cognitive function following systemic stress
12/12/2002US20020187976 New benzofurane derivatives, their preparation process, their use as medicaments and the pharmaceutical compositions containing them
12/12/2002US20020187975 Process for the manufacture of 117Sn diethylenetriaminepentaacetic acids
12/12/2002US20020187974 Method of chlamydia prophylaxis
12/12/2002US20020187973 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002US20020187972 Methods for modulating expression of exogenous genes in mammalian systems
12/12/2002US20020187970 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-DIOL
12/12/2002US20020187969 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002US20020187968 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-DIOL
12/12/2002US20020187967 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002US20020187966 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002US20020187965 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002US20020187964 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002US20020187963 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002US20020187962 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002US20020187961 Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists
12/12/2002US20020187959 Compositions and methods for treating mammals with modified alginates and modified pectins
12/12/2002US20020187958 Treatment of pain
12/12/2002US20020187957 Time release reverse transcriptase inhibitors
12/12/2002US20020187956 Method for treating tumors by the administration of tegafur, uracil, folinic acid, and cyclophosphamide
12/12/2002US20020187954 Insulin-like growth factor II antisense oligonucleotide sequences and methods of using same to modulate cell growth
12/12/2002US20020187953 Estrogen receptor-related receptor alpha (ERRalpha) and cartilage formation
12/12/2002US20020187947 Inflammation-related gene
12/12/2002US20020187946 Mammalian iap gene family, primers, probes and detection methods
12/12/2002US20020187945 Modulation of immune response by ribavirin
12/12/2002US20020187944 Inhibition of human immunodeficiency virus reverse transcriptase
12/12/2002US20020187943 Bioavailable composition of natural and synthetic hca
12/12/2002US20020187941 Pregabalin lactose conjugates
12/12/2002US20020187939 Use of inhibitors of the renin-angiotensin system
12/12/2002US20020187926 Combined use of derivatives of GLP-1 analogs and PPAR ligands
12/12/2002US20020187920 Dopamine D4 receptor antagonists as treatment for attention deficit-hyperactivity disorder
12/12/2002US20020187919 Methods for preventing pressure induced apoptotic neural cell death
12/12/2002US20020187542 Fatty-acid amide hydrolase
12/12/2002US20020187534 Treating cancer by increasing intracellular malonyl CoA levels
12/12/2002US20020187520 Allergen/ inflammatory testing and diagnosis
12/12/2002US20020187519 Treatment regimen for prostate cancer
1 ... 5622 5623 5624 5625 5626 5627 5628 5629 5630 5631 5632 5633 5634 5635 5636 5637 5638 5639 5640 5641 5642 ... 7860